Dermatol. praxi. 2022;16(3):145-149 | DOI: 10.36290/der.2022.028

Ageing woman at dermatology

doc. MUDr. Tomáš Fait, Ph.D.
Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha
Katedra zdravotnických studií, Vysoká škola polytechnická Jihlava

Menopause is conected and based on hard fall of the estrogen selfproduction. It induce negative changes in skin. Protective effects of any systemic estrogene therapy is clear and evidence-based. Hormone replacement therapy´s indication is temporary, it is why role of special cosmetics for ageing skin could not be ignore.

Keywords: menopause, hormone replacement therapy, skin, cosmetics.

Accepted: October 11, 2022; Published: October 17, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fait T. Ageing woman at dermatology. Dermatol. praxi. 2022;16(3):145-149. doi: 10.36290/der.2022.028.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fait T. Klimakterická medicína, 3. vydání. Praha: Maxdorf; 2018.
    2. Fait T, Zikán M, Mašata J. Moderní farmakoterapie v gynekologii a porodnictví. 3. aktualizované a přepracované vydání. Praha: Maxdorf; 2019.
    3. Fait T. Klimakterium, s. 315-320 in Rob L, Martan A, Ventruba P, a kol. Gynekologie. 3. vydání. 2019: 355 s.
    4. Kenemans P, Speroff L. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas. 2005;51(1):21-28. Go to original source... Go to PubMed...
    5. Salpeter SR, Walsh JM, Greyber E, et al. Mortality associa­ted with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med. 2004; 19(7):791-804. Go to original source... Go to PubMed...
    6. Fait T. Menopauzální genitourinární syndrom - těžký komunikační problém, snadná léčba. Cas Lek Ces 2019;158:101-106.
    7. Fait T, Kushniruk N. Předčasné ovariální selhání v každodenní praxi. Gynek Porod 2022;6(1):22-24.
    8. Fait T, Borovsky M. DT56a in treatment of climacteric syndrome in a Central European population sample. Bratislava Medical Journal 2021;122(5):301-304. Go to original source... Go to PubMed...
    9. Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human instestinal microflora. Mol Nutr Food Res 2007;51:765-781. Go to original source... Go to PubMed...
    10. Atkinson C, Newton KM, Bowless EJ, et al. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in USA. Am J Clin Nutr 2008;87:679-687. Go to original source... Go to PubMed...
    11. Raimondi S, Roncaglia L, De Lucia M, et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol 2009;81:943-950. Go to original source... Go to PubMed...
    12. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev, 2005;14(8):1847-1850. Go to original source... Go to PubMed...
    13. Thornton MJ. Estrogens and aging skin. Dermatoendocrinol. 2013;5(2):264-270. Go to original source... Go to PubMed...
    14. Takako K, Toshiyuki Y, Kanako Y, et al. Correlations of androstenediol with reproductive hormones and cortisol according to stages during the menopausal transition in Japanese women. J Steroid Biochem Mol Biol 2021;214:106009. Go to original source... Go to PubMed...
    15. Růžičková Jarešová I. Stárnutí kůže péče o ni. Medi. praxi. 2012;9(6-7):293-296.
    16. Zouboulis CC, Blume-Peytavi U, Kosmadaki M, et al. Skin, hair and beyond: the impact of menopause. Climacteric 2022;4:1-9. Go to original source... Go to PubMed...
    17. Saurat J.-H. Skin, Sun, and Vitamin A: From Aging to Cancer. J Dermatol 2001;28(11):595-598. Go to original source... Go to PubMed...
    18. Prottey C. Essential fatty acids and the skin. Br J Dermatol. 1976;94(5):579-587. Go to original source... Go to PubMed...
    19. Bouloc A, Roo E, Moga A, et al. A compensating skin care complex containing pro-xylane in menopausal women: results from a multicentre, evaluator-blinded, randomized study. Acta Derm Venerol. 2017;97:541-542. Go to original source... Go to PubMed...
    20. Thornton MJ. Oestrogen functions in skin and skin appendages. Expert Opin Ther Targets. 2005;9:617-629. Go to original source... Go to PubMed...
    21. Ashcroft GS, Ashworth JJ. Potential role of estrogens in wound healing. Am J Clin Dermatol. 2003;4:737-743. Go to original source... Go to PubMed...
    22. Tsukahara K, Nakagawa H, Moriwaki S, et al. Ovariecctomy is suficient to accelerate spontaneous skin ageing and to stimulate intraviolet irradiation - induced photoageing of murine skin. Br J Dermatol. 2004;151:984-994. Go to original source... Go to PubMed...
    23. Bottai G, Mancina R, Muratori M, et al. 17beta-estradiol protects human skin fibroblasts and keratinocytes against oxidative demage. J Eur Acad Dermatol Venerol. 2013;10: 1236-1243. Go to original source... Go to PubMed...
    24. Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: The Rhodes Island Follow-Back Study. J Invest Dermatol. 1994;102:6S-9S. Go to original source... Go to PubMed...
    25. Miller JG, Mac Nail S. Gender and cutaneous melanoma. Br J Dermatol. 1997;136:657-655. Go to original source...
    26. MacKie RM, Bray CA. Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. Br J Cancer. 2004;90(4):770-772. Go to original source... Go to PubMed...
    27. Botteri E, Støer NC, Sakshaug S, et al. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Int J Cancer. 2017;141(9):1763-1770. Go to original source... Go to PubMed...
    28. Brincat MP. Hormone replacement therapy and skin. Maturitas. 2000;35:107-117. Go to original source... Go to PubMed...
    29. Affinitio P, Paloma S, Sorrentno C, et al. Effect of postmenopausal hypoestrogenism on skin collagen. Maturitas. 1999;33:239-247. Go to original source... Go to PubMed...
    30. Santor PG, Schmidt JB, Rabe T, et al. The influence of HRT on skin ageing: a pilot study. Maturitas 2001;39:43-55. Go to original source... Go to PubMed...
    31. Philips TJ, Demicray Z, Sahu M. Hormonal effects on skin aging. Clin Geriatr Med. 2001;17:661-672. Go to original source... Go to PubMed...
    32. Brincat M, Versi E, Moniz CF, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol. 1987;70:123-127. Go to PubMed...
    33. Pierard-Franchimont C, Letawe C, Goffin V, et al. Skin waterholding capacity and transdermal estrogen therapy for menopause. Maturitas 1995;22:151-154. Go to original source... Go to PubMed...
    34. Shah MG, Maibach HI. Estrogen and skin: an overview. Am J Clin Dermatol. 2001;2:151-154. Go to original source... Go to PubMed...
    35. Maheux R, Naud F, Rioux M, et al. A ranomized, double blind, placebo-controlled study on effect of conjugated estrogens on skin thicknes. Am J Obstet Gynecol. 1994;170: 642-649. Go to original source... Go to PubMed...
    36. Varila F, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynecol. 1995;102:985-989. Go to original source... Go to PubMed...
    37. Duarte GV, Trigo ACM, de Oliveira M. Skin disorders during menopause. Cutis 2016;97:16-23. Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.